Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

TB-500 Research Gut Microbiome Considerations: Comparison

Fecal Butyrate Concentration Low butyrate (<15 mmol/kg) correlates with prolonged gut permeability and higher systemic IL-6 despite TB-500 administration Gas chromatography–mass spectrometry (GC-MS) of stool samples Target ≥20 mmol/kg 14–21 day prebiotic inter

This comparison does not assign a generated winner or score.

  • Fecal Butyrate Concentration
  • Low butyrate (<15 mmol/kg) correlates with prolonged gut permeability and higher systemic IL-6 despite TB-500 administration
  • Gas chromatography–mass spectrometry (GC-MS) of stool samples
  • Target ≥20 mmol/kg
  • 14–21 day prebiotic intervention with resistant starch (20g/day) or inulin (10g/day) to increase Roseburia and Faecalibacterium populations
  • Critical. Low butyrate is the single strongest predictor of TB-500 non-response in barrier repair studies
  • Proteobacteria Abundance
  • Proteobacteria >20% increases LPS translocation during TB-500's barrier-remodeling phase (days 3–7), creating transient inflammatory spike
  • 16S rRNA gene sequencing (V3-V4 regions) targeting phylum-level taxonomy
  • Target <10% relative abundance
  • Spore-based probiotics (Bacillus subtilis 2×10⁹ CFU/day) for 21 days pre-administration to competitively exclude gram-negative dysbiosis
  • High. Proteobacteria bloom is the primary driver of paradoxical inflammatory responses in early TB-500 protocols
  • Zonulin (Serum)
  • Elevated zonulin (>50 ng/mL) indicates pre-existing gut permeability. TB-500 will restore barrier but won't eliminate upstream dysbiosis driving permeability
  • ELISA assay on fasting serum sample
  • Target <40 ng/mL
  • Address root dysbiosis with antimicrobial herbs (berberine 500mg 3×/day, oregano oil) or elemental diet for 10–14 days before TB-500
  • Moderate. Zonulin is a marker, not a mechanism. Lowering it requires addressing the bacterial imbalance causing permeability
  • Fecal Calprotectin
  • Calprotectin >150 µg/g indicates active intestinal inflammation. TB-500's anti-inflammatory effects will be delayed until inflammation resolves
  • Immunoassay on stool sample (widely available clinical test)
  • Target <50 µg/g
  • 14-day anti-inflammatory intervention with curcumin (1000mg/day), omega-3s (2–3g EPA+DHA/day), and L-glutamine (10g/day) before TB-500
  • Moderate. Elevated calprotectin predicts slower barrier repair kinetics but doesn't prevent TB-500 efficacy
More references

Related material